News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TradingKey Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Baxter International Inc. (BAX) stock fell 2.39% to $26.95 on Wednesday, underperforming the broader market. This marked the second consecutive day of losses for the company, even as the S&P 500 Index rose 0.26% and the Dow Jones Industrial Average slightly declined by 0.04%.
Deepa Abi has been appointed as Vice President, Global Business Solutions at Baxter International Inc., bringing over 25 years of global leadership experience in healthcare, consumer goods, technology, and consulting. In her new role, she will lead the company's Global Business Solutions function, focusing …
Investing.com reported the filing of a Form 8K by Baxter International Inc. on August 11. The article provides the title of the filing and indicates it pertains to Baxter International, a company whose stock is tracked on financial markets.
Baxter International Inc. announced that Anita Zielinski, interim CFO, will resign effective September 15, 2026, to join another organization. The company stated her resignation is not due to any disagreements with management or the board. This information was disclosed in an SEC filing on …
Thirteen research firms have given Baxter International Inc. (NYSE:BAX) an average rating of "Reduce," with a collective price target of $22.45, below its current trading price of $27.84. Despite this cautious outlook, Baxter International reported strong quarterly results, exceeding analyst expectations with an adjusted …
Sharemaestro market context Trend signal active 52 weeks +9.8%Baxter International (NYSE:BAX) stock recently crossed above its 200-day moving average, trading at $27.84, significantly higher than its average of $19.93. The company reported strong quarterly earnings, exceeding analyst expectations with an adjusted EPS of $0.56 and revenue of $2.96 billion. Despite positive financial …
Levi & Korsinsky, LLP has filed a class action securities lawsuit against Baxter International, Inc. (NYSE: BAX) on behalf of shareholders who suffered losses due to alleged securities fraud between February 23, 2022, and July 30, 2025. The lawsuit claims Baxter made false statements …
Baxter International Inc. (BAX) shares increased by 2.00% to $27.55 on Friday, outperforming the broader stock market, which also saw gains. The S&P 500 Index rose 0.62%, and the Dow Jones Industrial Average gained 0.28%. This rise broke a two-day losing streak for Baxter …
In early August 2026, Cardinal Health announced that Anita Zielinski will become Chief Accounting Officer in November, following her interim CFO and senior accounting roles at Baxter and long tenure at Sysco and Ernst & Young, while the company also faced ongoing Class II …
Sharemaestro market context Trend signal active 52 weeks +5.5%This article provides a Morningstar analyst report on Baxter International Inc. (BAX), detailing its 2026 outlook, revenue growth, and tariff refund impact. The report, authored by senior analyst Julie Utterback, assigns a rating and fair value to BAX, describing the company's offerings in medical …
Baxter International Inc. (BAX) shares fell 1.17% on Thursday, closing at $27.01, underperforming the broader market. The S&P 500 Index dropped 0.18%, and the Dow Jones Industrial Average declined by 0.85%, making it the second consecutive day of losses for Baxter's stock.
Baxter International announced that Anita Zielinski will resign as Interim CFO and Senior Vice President, Chief Accounting Officer and Controller, effective September 15, 2026, to join another company. The company clarified that her departure is not due to any disagreements regarding operations or financial …
Baxter International announced that Interim Chief Financial Officer Anita Zielinski will resign effective September 15, 2026, to join another company. Her resignation, communicated on July 31, 2026, is not due to any disagreements with management or the board regarding operations, policies, financial disclosures, or …
JPMorgan has raised its price target for Baxter International (BAX) to $26 from $19, while maintaining a Neutral rating on the stock. This adjustment comes after other analysts, including UBS, Wells Fargo, Jefferies & Co, Deutsche Bank, and Citigroup, also updated their price targets …
DEERFIELD, Ill., August 04, 2026--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced that it has commenced cash tender offers (each, an "Offer" and collectively, the "Offers") for the maximum principal amount of validly tendered (and not validly withdrawn) notes set forth …
Sharemaestro market context Trend signal active 52 weeks +5.5%Baxter International has commenced cash tender offers to repurchase up to $500 million of select senior notes, providing an early tender premium of $30 per $1,000. The offer prioritizes notes from 2051, 2046, 2043, and 2032, with an early settlement option for tenders by …
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Baxter International is back in focus after the fair value estimate in one widely used model moved from US$21.54 to US$27.29, a change of about 27% that …
Sharemaestro market context Trend signal active 52 weeks +5.5%Baxter International Inc. recently reported past Q2 2026 results, with sales rising to US$2,960 million and quarterly net income increasing to US$126 million compared with the prior year. Alongside this, Baxter raised its 2026 sales growth and adjusted earnings guidance while maintaining a quarterly …
Sharemaestro market context Trend signal active 52 weeks +5.5%Wells Fargo has increased its target price for Baxter International Inc. (BAX.N) shares to $23 from the previous $19. This adjustment reflects an updated outlook from the financial institution regarding the medical products company. The information is sourced from Reuters.
Baxter International's stock slipped 2% despite beating Q2 revenue and adjusted EPS expectations and raising full-year guidance. While the company showed progress in its turnaround with organic revenue growth and improved free cash flow, concerns remain about compressed margins and execution risks, including ongoing …
Baxter International Inc. (BAX) saw its stock rise 23.4% after reporting increased Q2 2026 sales and net income, leading to an upgraded full-year sales and earnings guidance for continuing operations. Despite this, first-half 2026 net income was lower year-over-year, indicating persistent early-year profitability pressures. …
Shares of Baxter International Inc. (BAX) fell by 2.21% on Friday, closing at $26.16, despite an overall positive trading session for the stock market. This decline broke a five-day winning streak for the company's stock. The S&P 500 Index and the Dow Jones Industrial …
Deutsche Bank has adjusted its price target for Baxter International (NYSE: BAX) to $27, an increase from the previous target of $20. The firm has decided to maintain its Hold rating on the stock.
Baxter International Inc. (NYSE: BAX) is scheduled to go ex-dividend on August 28th, 2026. Shareholders will receive a dividend of 0.01 USD per share. This information is key for investors looking to receive the upcoming dividend payment.
Baxter International Inc. (BAX) has experienced significant stock performance fluctuations, underperforming the S&P 500 over the last year but outperforming it year-to-date. The company recently exceeded Q2 FY2026 earnings expectations, revised its full-year guidance upward, and maintains a "Hold" consensus rating from analysts, with …
The average 12-month price target for Baxter International Inc. (BAX) stock has been raised from $21.4 to $23.1 by 10 analysts, with a range of $17 to $32. Based on the July 29 closing price, this new target suggests a potential 7% downside. The …
Baxter International reported its second-quarter earnings per share at 24 cents. This indicates the company's financial performance for the recent quarter.
Baxter International Inc. reported strong Q2 2026 results with global sales increasing 5% to approximately $3 billion, driven by robust performance across all segments. Despite a decline in adjusted EPS due to higher manufacturing costs and an ongoing hold on a key infusion pump, …
Sharemaestro market context Trend signal active 52 weeks +5.5%Baxter International (BAX) reported strong Q2 earnings of $0.56 per share, significantly beating the Zacks Consensus Estimate of $0.36, and exceeded revenue expectations with $2.96 billion. Despite this positive performance, the company currently holds a Zacks Rank #4 (Sell) due to unfavorable estimate revisions. …
Sharemaestro market context Trend signal active 52 weeks +5.5%Shares of Baxter International (BAX) jumped 8.7% after the company reported second-quarter results that surpassed analyst expectations for both revenue and earnings per share. The company also raised its full-year financial forecast, highlighting strong operational performance. This positive news comes shortly after TD Cowen …
Search by ticker symbol or company name and select a result to open its chart.